Solventum Corp reported $3.58B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Align Technology USD 1.91B 4.9M Sep/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Cencora USD 59.2B 3.06B Jun/2026
Dexcom USD 2.25B 105.1M Sep/2026
Insulet USD 814.4M 70.2M Sep/2026
Solventum Corp USD 3.58B 88M Sep/2026
West Pharmaceutical Services USD 644.3M 3.8M Sep/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026